Successful outcome of liver transplantation in a patient with hepatitis C and common variable immune deficiency

Transplant International

Volumn 15, Issue 7, 2002, Pages 380-383

  Gow, Paul J ^a   Mutimer, David ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Common variable immune deficiency; Fibrosing cholestatic hepatitis; Hepatitis C virus; Liver transplant; Viral clearance

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CIPROFLOXACIN; CYCLOSPORIN; FLUCONAZOLE; IMMUNOGLOBULIN G; INTERFERON; PREDNISOLONE; RIBAVIRIN;

ADULT; ARTICLE; CASE REPORT; CHOLESTATIC HEPATITIS; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; CONTAMINATION; DISEASE COURSE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECURRENT INFECTION; TREATMENT INDICATION; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; COMMON VARIABLE IMMUNODEFICIENCY; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036943825     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2002.tb00183.x     Document Type: Article

References (15)

1. Bjoro K, Skaug K, Haaland T, Froland SS (1999) Long-term outcome of chronic HCV virus infection in primary hypogammaglobulinaemia. QJM 92:433-441
2. Bresee JS, Mast EE, Coleman PJ, Baron MJ, Schonberger LB, Alter MJ, Jonas MM, Yu MY, Renzi PM, Schneider LC (1996) HCV virus infection associated with administration of intravenous immune globulin. A cohort study. JAMA 276:1563-1567
3. Charlton M, Seaberg E (1999) Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Liver Transpl Surg 5[Suppl 1]:S107-114
4. Christie JM, Healey CJ, Watson J, Wong VS, Duddridge M, Snowden N, Rosenberg WM, Fleming KA, Chapel H, Chapman RW (1997) Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute HCV: 2-year follow up. Clin Exp Immunol 110:4-8
5. Dickson RC, Caldwell SH, Ishitani MB, Lau JY, Driscoll CJ, Stevenson WC, McCullough CS, Pruett TL (1996) Clinical and histologic patterns of early graft failure due to recurrent HCV in four patients after liver transplantation. Transplantation 61:701-705
6. Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reynes M, Okamoto H, Bismuth H, Brechot C (1995) Influence of the genotypes of HCV virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 108:1088-1096
7. Gane EJ, Naoumov NV, Qian KP, Mondelli MU, Maertens G, Portmann BC, Lau JY, Williams R (1996) A longitudinal analysis of HCV virus replication following liver transplantation. Gastroenterology 110:167-177
8. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P, Walker BD (2000) Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191:1499-1512
9. Schluger LK, Sheiner PA, Thung SN, Lau JY, Min A, Wolf DC, Fiel I, Zhang D, Gerber MA, Miller CM, Bodenheimer HC Jr (1996) Severe recurrent cholestatic HCV following orthotopic liver transplantation. Hepatology 23:971-976
10. Sheiner PA, Schwartz ME, Mor E, Schluger LK, Theise N, Kishikawa K, Kolesnikov V, Bodenheimer H, Emre S, Miller CM (1995) Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 21:30-34
11. Sheiner PA, Boros P, Klion FM, Thung SN, Schluger LK, Lau JY, Mor E, Bodian C, Guy SR, Schwartz ME, Emre S, Bodenheimer HC Jr, Miller CM (1998) The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology 28:831-838
12. Smith MS, Webster AD, Dhillon AP, Dusheiko G, Boulton R, Savage K, Rolles K, Burroughs AK (1995) Orthotopic liver transplantation for chronic hepatitis in two patients with common variable immunodeficiency. Gastroenterology 108:879-884
13. Tanno H, Fay OH, Rojman JA, Palazzi J, Bessone F (1988) HBeAg/anti-HBe seroconversion during and after protracted immunosuppressive treatment in type B chronic hepatitis. Med Virol 25:45-51
14. Toth CM, Pascual M, Chung RT, Graeme-Cook F, Dienstag JL, Bhan AK, Cosimi AB (1998) HCV virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy. Transplantation 66:1254-1258
15. Yoshikawa M, Toyohara M, Yamane Y, Mimura M, Miyamoto Y, Ueda S, Kawamoto H, Fukui H, Kobayashi T, Hayashi E, Nakamura A (1999) Disappearance of serum HCV-RNA after short-term prednisolone therapy in a patient with chronic hepatitis C associated with autoimmune hepatitis-like serological manifestations. J Gastroenterol 34:269-274